Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb randomized double-blind placebo- and active-controlled study of sodium danshensu injection in stable angina
CTR20262950Phase 2Active
- Sponsor
- Naval Medical University
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of danshensu in stable angina and coronary arteriosclerosis (3 arms), sponsored by Naval Medical University. Primary endpoint: Change from baseline in total exercise duration on treadmill exercise test. Started Aug 2026; status: active.
02
Drugs
danshensu
03
Conditions
stable anginacoronary arteriosclerosis
Beyond the preview
Go deeper on CTR20262950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262950.